行情

AKRX

AKRX

爱克龙药业
NASDAQ

实时行情|Nasdaq Last Sale

4.090
-0.010
-0.24%
盘后: 4.090 0 0.00% 16:09 11/15 EST
开盘
4.130
昨收
4.100
最高
4.200
最低
4.040
成交量
69.48万
成交额
--
52周最高
7.25
52周最低
2.340
市值
5.16亿
市盈率(TTM)
-1.4095
分时
5日
1月
3月
1年
5年

分析师评级

8位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

AKRX 新闻

  • The Zacks Analyst Blog Highlights: Forterra, Barrett Business, Chuy's, Akorn and Quanex
  • Zacks.5天前
  • 5 Small-Cap Stocks Outpacing the Broader Market in 2019
  • Zacks.6天前
  • New Strong Buy Stocks for November 7th
  • Zacks.11/07 13:22
  • Akorn to Present at the Credit Suisse Healthcare Conference
  • GlobeNewswire.11/06 00:00

更多

所属板块

制药
+1.37%
制药与医学研究
+1.34%

热门股票

名称
价格
涨跌幅

AKRX 简况

Akorn Inc. (Akorn), together with its subsidiaries, is a specialty generic pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals, as well as private-label over-the-counter (OTC) consumer health products and animal health pharmaceuticals. The Company operates through two segments: Prescription Pharmaceuticals and the Consumer Health. The Prescription Pharmaceuticals segment consists of generic and branded prescription pharmaceuticals in a range of dosage forms, including sterile ophthalmics, injectables and inhalants and non-sterile oral liquids, topicals and nasal sprays and otics. The Consumer Health segment consists of branded and private-label OTC products and animal health products dispensed by veterinary professionals. Its branded and private-label OTC products are focused on ophthalmics, including a dry eye treatment TheraTears Therapy for Your Eyes.
展开

Webull提供Akorn, Inc.的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。